CRVO · CervoMed Inc. · Executive Compensation
$2.29
-0.02 (-0.87%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 7, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 7, 2026Market Cap
$34.62M
Shares
15.12M
Volume · Oct 20
134.53K
Avg daily vol (3M)
286.37K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William K. Hornung | Chief Financial Officer | $355,134 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| David G. Kalergis | Chief Executive Officer | $587,141 |
| John L. Gainer | Former Chief Scientific Officer | $507,037 |
| William K. Hornung | Chief Financial Officer | $381,462 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David Quigley | director | Appointed | 2025-10-29 |
| Mark De Rosch | Executive Vice President, Regulatory and Government Affairs and Program Management | Appointed | 2025-04-18 |
| Kelly Blackburn | Executive Vice President, Clinical Development | Appointed | 2025-04-18 |
| William Elder | Principal Accounting Officer | Appointed | 2024-05-20 |
| J. William Tanner, Ph.D. | Chief Financial Officer | Terminated | 2024-05-20 |
| William Elder | Principal Financial Officer | Appointed | 2024-05-20 |
| William Elder | Chief Financial Officer | Appointed | 2024-05-20 |
| Joshua S. Boger, Ph.D. | Chair of the Board | Appointed | 2024-02-07 |
| Joshua S. Boger, Ph.D. | director | Appointed | 2024-02-07 |
| Robert J. Cobuzzi, Jr., Ph.D. | Chief Operating Officer | Appointed | 2024-02-02 |
| J. William Tanner, Ph.D. | Chief Financial Officer | Appointed | 2023-11-17 |
| Robert J. Cobuzzi, Jr., Ph.D. | Director | Appointed | 2023-11-08 |
| Jill Davidson | Board of Directors | Resigned | 2023-10-31 |
| Frank Zavrl | Director | Appointed | 2023-08-17 |
| Sylvie Grégoire, PharmD. | director | Appointed | 2023-08-17 |
| Jeff Poulton | Director | Appointed | 2023-08-17 |
| Marwan Sabbagh, M.D. | Director | Appointed | 2023-08-17 |
| John Alam, M.D. | director | Appointed | 2023-08-17 |
| Sylvie Grégoire, PharmD. | Chair of the Board of Directors | Appointed | 2023-08-17 |
| William Tanner, Ph.D. | Chief Financial Officer (Principal Financial Officer) | Appointed | 2023-08-17 |
| John Alam, M.D. | Chief Executive Officer, President and Director (Principal Executive Officer) | Appointed | 2023-08-17 |
| William Elder | Principal Financial Officer | Resigned | 2023-08-17 |
| Robert J. Cobuzzi, Jr., Ph.D. | Chief Operating Officer | Appointed | 2023-08-17 |
| Robert J. Cobuzzi, Jr., Ph.D. | director | Resigned | 2023-08-17 |
| Diana Lanchoney, M.D. | board of directors | Resigned | 2023-08-17 |
Leadership
- John Alam, M.D. CEO, Board Member
- Robert J. Cobuzzi CEO
- Robert J. Cobuzzi Jr., Ph.D. CEO
- Robert J. Cobuzzi, PhD. CEO
- Joshua S. Boger, Ph.D. Chairman, Board Member
- Sylvie Grégoire, Pharm.D. Chairman
- Sylvie Grégoire, PharmD. Chairman, Board Member
- J. William Tanner, Ph.D. CFO
- William Elder CFO, Chief Accounting Officer
- William R. Elder CFO, General Counsel
- William Tanner, Ph.D. CFO
- Robert J. Cobuzzi, Jr., Ph.D. COO
- David Quigley Board Member
- Frank Zavrl Board Member
- Jane H. Hollingsworth Board Member
- Jeff Poulton Board Member
- Jill Davidson Board Member
- John Alam Board Member
- Joshua S. Boger Board Member
- Marwan Sabbagh Board Member
- Marwan Sabbagh, M.D. Board Member
- Robert J. Cobuzzi, Ph.D. Board Member
- Sylvie Grégoire Board Member